Drno, B., Pcastaings, S., Corvec, S., Veraldi, S., Khammari, A., & Roques, C
CA: Wow
The battery keeps the light running
To get some perspective on this and to learn more about the prohibition of clove and other flavored cigarettes, we spoke to John Geoghegan, director of brand development for Moorpark, Calif.-based Kretek International , the now former importer of the Djarum brand clove cigarettes
99) 41cec9a747ce908d68ae70feb198a4cb Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections
1 , 2 , 4 A meta-analysis of 3 RCTs comparing DOACs with VKAs after PCI, PIONEER AF-PCI (Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with Atrial Fibrillation who Undergo Percutaneous Coronary Intervention) (rivaroxaban), RE-DUAL PCI trial (Randomized Evaluation of Dual Antithrombotic Therapy with Dabigatran versus Triple Therapy with Warfarin in Patients with Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) (dabigatran), and AUGUSTUS (Open-Label, 22 Factorial, Randomized, Controlled Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention) (apixaban), showed a 42% relative risk reduction for major bleeding in DOAC-based regimens compared with VKA-based regimens (OR, 0.577 [95% CI, 0.477-0.698]
